Biopharmaceuticals are large molecules, used as medicinal drugs. Biopharmaceutical drugs are produced through complex biotechnological methods involving recombinant DNA techniques, hybridoma techniques, and purification processes. Biopharmaceutical production involves the use of living microorganisms, plants, or animal cells. These drugs help in prevention and treatment of various diseases such as cardiovascular disease, rheumatoid arthritis, psoriatic arthritis, psoriasis, anaemia arising from chemotherapy, chronic renal failure, cancer, and diabetes. Technological advancements in biopharmaceuticals have revolutionized the treatment of many serious and chronic illnesses, based on which the demand for biopharmaceutical products would greatly be boosted during the forecasted period. There are more than 300 approved biopharmaceutical drugs; the anti-inflammatory drug Humira is one of the best-selling drugs worldwide.
Factors such as increasing incidence of chronic diseases, rising geriatric population and increased R&D investments for formulation and development of biologics are fuelling the growth of the biopharmaceutical market during the forecasted period. Currently more than thousand large molecules are undergoing clinical trials. Furthermore, the rise in strategic collaborations between biopharmaceutical companies and Contract Research Organization & Contract Manufacturing Organization is also expected to spur the growth of the biopharmaceutical market. In addition, technological advancement in biopharmaceutical manufacturing and expansion of biosimilar are also helping to boost the demand of biopharmaceutical products during the forecasted period. However, cost containment, stringent regulation are some factors, which are restraining the growth of the biopharmaceuticals market.
Request for Sample Report- https://www.gmiresearch.com/report/global-biopharmaceuticals-market/sample-request
Various notable players operating in the market, include Sanofi, F. Hoffmann-La Roche, AbbVie Inc, Pfizer, Inc., Merck & Co., Inc., Novartis AG, Johnson & Johnson, GlaxoSmithKline, Eli Lilly and Company, AstraZeneca PLC, Bayer AG among others. Major players are focussing on R&D activities and strategic acquisition and merger activities to hold their leadership in this market. For instance, in 2018, Sanofi acquired Ablynx to expands growing rare blood disorders franchise with Ablynx’s late-stage investigational caplacizumab.
The global biopharmaceuticals market has been segmented on the basis of product type, therapeutics application and key geographies. Based on product type, the market comprises of tissue intravascular cooling and intravascular warming. The research report “global biopharmaceuticals market” provides in-depth analysis of global biopharmaceuticals market based on product type, therapeutics application and major geographies for the forecasted period, from 2018 to 2025. The report also highlights the major market drivers propelling the growth as well as challenges faced by market participants. The research report provides market size and forecast for the global biopharmaceuticals market. In addition, the report also analyses the competitive landscape, major players and their strategies in 2018. The competitive landscape section of the report captures and highlights the recent developments in the market.
Request for Customization – https://www.gmiresearch.com/report/global-biopharmaceuticals-market/request-for-customization
Key questions answered in this research report:
1- At what pace is biopharmaceuticals market growing? What
will be growth trend in future?
2- What are the key drivers and restraints in the current
market? What will be the impact of drivers and restraints in the future?
3- What are the regional revenue and forecast breakdowns?
Which are the major regional revenue pockets for growth in the
biopharmaceuticals market?
4- What are the various application areas and how they are
poised to grow?
For Additional Insights, Click to Access Complete Report – https://www.gmiresearch.com/report/global-biopharmaceuticals-market/
About GMI Research
GMI Research is a market research and consulting firm which provides research-based solutions to business executives and investment professionals so that they can make right business & investment decisions faster based on real facts. We help business leaders through independent fact-based insight, ensuring their business achieve success by beating the competition. GMI Research’s leadership team with extensive experience in research and consulting together with our research and domain expertise creates a strong value proposition to create solutions that addresses our client’s business problems and add significant value to long lasting relationship.
The company provides syndicated research report, customized research, sales enablement research, data analytics and KPO (knowledge process outsourcing) service for Electronics & Semiconductors, Information Communication and Technology, Energy & Power, Healthcare, Automotive, Transportation & Logistics and Chemical industries. Our analysts and consultants who are passionate about research and consulting are recruited from renowned local and global universities and have worked with the leading local and international organizations.
Contact Us
Company Name: GMI RESEARCH
Contact Person: Sarah Nash
Email: enquiry@gmiresearch.com
Phone: +353 1 442 8820
Address: Level 1, The Chase Carmanhall Road, Sandyford Industrial Estate
City: Dublin
State: Dublin
Country: Ireland
Website: http://www.gmiresearch.com
gmiresearch1 